An Independent Review
Home About Us Contact Us Index Search Consumer Topics Back Issues

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

rabeprazole
  • proton pump inhibitor - Pariet (New drug) 24(2) 43-7
    		•
    rabies vaccine
  • Rabipur (New drug) 29(1) 25-7
    		•
    Rabipur
  • see rabies vaccine 29(1) 25-7
    		•
    RADAR (Rational Assessment of Drugs and Research)
  • ezetimibe 27(5) 128
    		•
  • risperidone in behavioural disturbances in dementia 28(3) 71
    		•
  • Underneath the RADAR 26(6) 131
    		•
    radioallergosorbent tests (RAST)
  • abnormal laboratory results 25(4) 91-3
    		•
    radiography
  • 'Pocket guide to chest X-rays' (book review) 27(6) 158
    		•
    radiology
  • barium meals vs endoscopy (letter) 19(3) 59-62
    		•
  • bowel preparation 28(1) 16-7
    		•
    radiosynovectomy
  • in rheumatoid arthritis (letter) 26(5) 99-102
    		•
    radiotherapy
  • salivary glands and xerostomia 29(4) 97-8
    		•
  • dental notes 29(4) 108
    		•
  • letters 30(1) 3-4
    		•
    raloxifene
  • osteoporosis - Evista (New drug) 22(4) 95-8
    		•
  • women at risk of breast cancer 25(6) 139-41
    		•
    raltitrexed
  • colorectal cancer 25(5) 108-10; 25(5) 111-3
    		•
  • colorectal cancer - Tomudex (New drug) 19(4) 108-11
    		•
    ramipril
  • Tritace (New strength) 24(4) 100-2
    		•
    ranibizumab
  • Lucentis - macular degeneration (New drug) 30(3) 79-82
    		•
    Ranihexal
  • see ranitidine 22(6) 147-51
    		•
    ranitidine
  • Ausran (New brand) 23(3) 64-7
    		•
  • hepatotoxicity (letter) 19(4) 92-3
    		•
  • hydrochloride - SBPA Ranitidine (New brand) 23(1) 21-3
    		•
  • new formulation - Zantac 17(2) 30-2
    		•
  • pharmacology 23(3) 57-9
    		•
  • Ranoxyl (New brand) 23(1) 21-3
    		•
    Ranoxyl
  • see ranitidine 23(1) 21-3
    		•
    Rapamune
  • see sirolimus 25(6) 147-51; 25(4) 94-9
    		•
    Rapifen
  • see alfentanil 20(2) 45-51
    		•
    Rapilysin
  • see reteplase 24(1) 20-3; 21(3) 80-3
    		•
    Raptiva
  • see efalizumab 28(1) 19-23
    		•
    rasburicase
  • hyperuricaemia - Fasturtec (New drug) 26(3) 68-71
    		•
    rasburicase rys
  • Fasturtec (New formulation) 27(6) 159-65
    		•
    Rational Assessment of Drugs and Research (RADAR)
  • (see also Underneath the RADAR) 26(6) 131
    		•
    Rebetron Combination Therapy
  • see interferon alfa-2b - ribavirin 23(1) 21-3
    		•
    Rebif
  • see interferon beta 1a 23(3) 64-7
    		•
  • see interferon beta-1a 25(2) 32-5
    		•
    reboxetine mesylate
  • antidepressant - Edronax (New drug) 25(5) 120-3
    		•
    recombinant factor IX
  • haemophilia - Benefix (New drug) 24(3) 71-5
    		•
    recombinant factor VIIa
  • haemophilia - NovoSeven (New drug) 22(4) 95-8
    		•
    recombinant factor VIII
  • haemophilia - moroctocog - Refacto (New drug) 25(4) 94-9
    		•
  • haemophilia A - Recombinate (New drug) 19(1) 24-7
    		•
    Recombinate
  • see recombinant factor VIII 19(1) 24-7
    		•
    Reductil
  • see sibutramine 25(1) 20-3
    		•
    Refacto
  • see moroctocog 25(4) 94-9
    		•
    reference pricing
  • drug price reforms (editorial) 30(6) 138-40
    		•
    Refludan
  • see lepirudin 23(4) 84-7
    		•
    rehabilitation
  • in back pain 17(2) 33-6
    		•
  • transcutaneous electrical nerve stimulation (letter) 18(1) 4-7
    		•
    rehydration
  • oral in childhood gastroenteritis (letter) 17(1) 4-5
    		•
    Relenza
  • see zanamivir 22(3) 70-1
    		•
    Remeron
  • see mirtazapine 24(3) 71-5
    		•
    Remicade
  • see infliximab 24(2) 43-7
    		•
    remifentanil
  • analgesia - Ultiva (New drug) 21(4) 108-11
    		•
    Reminyl
  • see galantamine 27(4) 101-5; 24(4) 100-2
    		•
    Remodulin
  • see treprostinil 27(6) 159-65
    		•
    remoxipride
  • antipsychotic - Roxiam (New drug) 17(1) 6-8
    		•
    Renagel
  • see sevelamer 28(6) 156-8
    		•
    renal - see kidney
    renal cell carcinoma
  • aldesleukin - Proleukin (New drug) 23(4) 84-7
    		•
    Renitec
  • see enalapril maleate - hydrochlorothiazide 24(1) 20-3
    		•
    ReoPro
  • see abciximab 19(3) 81-3
    		•
    repaglinide
  • drug interactions 24(4) 83-5
    		•
  • type 2 diabetes - NovoNorm (New drug) 23(4) 84-7
    		•
    Replagal
  • see agalsidase alfa 27(5) 131-3
    		•
    Repreve
  • see ropinirole 28(1) 19-23
    		•
    Rescriptor
  • see delarvidine 21(2) 49-55
    		•
    respiration disorders
  • air travel 23(5) 107-9
    		•
  • nitric oxide - neonatal respiratory failure - INOmax (New drug) 31(1) 24-7
    		•
  • Therapeutic Guidelines - book review 28(5) 129
    		•
    respiratory distress syndrome
  • dental implications 23(1) 21
    		•
  • modified bovine lung extract (beractant) - artificial surfactant - Survanta (New drug) 18(1) 7-9
    		•
  • respiratory function tests 23(1) 10-2
    		•
    respiratory distress syndrome, neonatal
  • poractant alfa - Curosurf (New drug) 28(3) 75-9
    		•
    respiratory syncitial virus infections
  • palivizumab - Synagis (New drug) 22(5) 125-7
    		•
    respiratory tract infections
  • antibiotics 19(2) 48-51
    		•
  • antibiotics and antibiotic resistance 22(2) 37-9
    		•
  • management of aspiration pneumonia 26(1) 14-7
    		•
  • palivizumab - RSV infection - Synagis (New drug) 22(5) 125-7
    		•
  • intravenous infusion lines (letters) 18(3) 56-7
    		•
  • pneumonia 22(2) 37-9
    		•
  • steroids in croup 20(4) 99-101
    		•
    restless legs syndrome
  • cabergoline-induced valvulopathy (medicinal mishap) 31(1) 21
    		•
  • ropinirole - Repreve (New drugs) 28(1) 19-23
    		•
    resuscitation
  • cardiopulmonary 20(2) 41-5
    		•
  • letters 21(3) 60-3; 20(4) 83-6
    		•
    Retaane
  • see anecortave 29(2) 53-5
    		•
    reteplase
  • myocardial infarction - Rapilysin (New drug) 21(3) 80-3
    		•
  • Rapilysin (New formulation) 24(1) 20-3
    		•
    retinal disease
  • drug treatment 25(5) 116-9
    		•
  • macular degeneration - anecortave - Retaane (New drug) 29(2) 53-5
    		•
  • patient support organisations 25(5) 115
    		•
    retinitis
  • cytomegaloviral - cidofovir - Vistide (New drug) 22(2) 43-7
    		•
  • cytomegaloviral - valganciclovir - Valcyte (New drug) 25(6) 147-51
    		•
    retinoids
  • tazarotene - Zorac - psoriasis, acne (New drug) 29(3) 84-7
    		•
    Revasc
  • see desirudin 23(6) 137-9
    		•
    ReVia
  • see naltrexone 22(5) 103-5; 22(2) 43-7
    		•
    Reyataz
  • see atazanavir - HIV infection 27(6) 159-65
    		•
    Rezulin
  • see troglitazone 22(6) 147-51
    		•
    rhabdomyolysis
  • cerivastatin/gemfibrozil combination 24(5) 109
    		•
  • statins and muscle damage (editorial) 26(4) 74-5
    		•
    Rhesus D - immunoglobulins
  • blood donation 23(2) 36-8
    		•
  • letter 24(4) 80-2
    		•
  • New strength 24(4) 100-2
    		•
    rheumatoid arthritis
  • abatacept - Orencia (New drug) 30(6) 163-7
    		•
  • abnormal laboratory results - antibodies to cyclic citrullinated peptides 29(6) 162-4
    		•
  • tumour necrosis factor inhibitors 27(2) 43-6
    		•
    rheumatoid factor
  • abnormal laboratory results - rheumatoid arthritis 29(6) 162-4
    		•
    rheumatology - see also arthritis; anti-inflammatory drugs
  • corticosteroids 21(1) 11-4
    		•
  • COX inhibitors (editorial) 23(2) 26-7
    		•
  • drug therapy of adult rheumatoid arthritis 26(2) 36-40
    		•
  • letter - radiosynovectomy 26(5) 99-102
    		•
  • letter - sulfasalazine 26(4) 75-7
    		•
  • etanercept - Enbrel (New drug) 25(1) 20-3
    		•
  • leflunomide - Arava (New drug) 23(1) 21-3
    		•
  • NSAIDS and cardiovascular disease (editorial) 29(4) 90-1
    		•
  • Therapeutic Guidelines - book review 29(5) 124
    		•
  • tumour necrosis factor inhibitors 29(3) 67-70; 27(2) 43-6
    		•
  • letter 28(1) 5-7
    		•
    rhinitis, allergic
  • azelastine - AZEP (New drug) 25(2) 44-7
    		•
  • fexofenadine - Telfast (New drug) 20(2) 45-51
    		•
  • letter 20(4) 83-6
    		•
  • immunotherapy 26(4) 91-3
    		•
    rhinosinusitis
  • cephalosporins (letter) 23(6) 115-7
    		•
  • dental implications 23(2) 43
    		•
  • management 23(2) 39-42
    		•
  • letters 23(5) 93-6
    		•
    Riamet
  • see artemether/lumefantrine 26(3) 68-71
    		•
    ribavirin
  • with interferon alfa-2b - Rebetron Combination Therapy (New combination) 23(1) 21-3
    		•
  • with peginterferon alfa-2a - Pegasys - chronic hepatitis C (New drug) 26(6) 146-51
    		•
  • with peginterferon alfa-2b - Pegatron Combination Therapy (New combination) 26(1) 22-3
    		•
  • peginterferon/ribavirin combination in hepatitis C 29(2) 36-9
    		•
    ridogrel
  • in antiplatelet therapy 19(4) 104-8
    		•
    rifabutin
  • Mycobacterium infections - Mycobutin (New drug) 17(4) 87-90
    		•
    rifampicin
  • MRSA infections - Orphan Drug Scheme (letter) 29(1) 3-5
    		•
    rifampicin in osteomyelitis
  • in meningococcal disease 22(5) 117-8
    		•
  • and oral contraceptives (letter) 23(2) 27-8
    		•
  • PBAC question 17(4) 95
    		•
    Rilutek
  • see riluzole 25(4) 94-9
    		•
    riluzole
  • amyotrophic lateral sclerosis - Rilutek (New drug) 25(4) 94-9
    		•
    ringworm
  • antifungal drugs 19(3) 72-5
    		•
    risedronate
  • in osteoporosis 23(6) 133-6
    		•
  • osteoporosis, Paget's disease - Actonel (New drug) 24(1) 20-3
    		•
    risk
  • consumers' vs doctors' perceptions of risk 26(1) 20-1
    		•
  • ethical issues 26(2) 44-5
    		•
  • 'Health care and notions of risk' (book review) 27(6) 159
    		•
  • interpreting risks and ratios in clinical trials 31(1) 12-6
    		•
  • pharmacotherapy for risk factors 30(2) 47-50
    		•
  • letter 30(4) 88-90
    		•
  • vs benefit - evaluation in drug therapy 24(1) 18
    		•
    Risperdal
  • see risperidone 28(3) 71
    		•
    Risperdal Quicklet
  • see risperidone 27(4) 101-5
    		•
    Risperidal
  • see risperidone 17(4) 87-90
    		•
    risperidone
  • antipsychotic - Risperidal (New drug) 17(4) 87-90
    		•
  • in behavioural disturbances in dementia (RADAR comment) 28(3) 71
    		•
  • new antipsychotic drugs 22(4) 81-3
    		•
  • Risperdal Quicklet (New formulation) 27(4) 101-5
    		•
    ritonavir
  • HIV - Norvir (New drug) 20(1) 22-3
    		•
  • lopinavir combination - HIV - Kaletra (New drug) 24(6) 155-8
    		•
    rituximab
  • lymphoma - antineoplastic antibodies 26(6) 141-3
    		•
  • lymphoma - Mabthera (New drug) 22(1) 20-3
    		•
    rivastigmine
  • Alzheimer's disease - Exelon (New drug) 23(5) 110-1
    		•
    rocuronium bromide
  • neuromuscular blocker - Esmeron (New drug) 18(4) 86-7
    		•
    rofecoxib
  • pharmacology of COX inhibitors 23(2) 30-2
    		•
  • vascular effects of COX-2 selective inhibitors 27(6) 142-5
    		•
  • letter 28(2) 29-33
    		•
    Rohypnol
  • see flunitrazepam 22(6) 147-51
    		•
    ropinirole
  • Repreve - restless legs syndrome (New drug) 28(1) 19-23
    		•
    ropivacaine
  • with fentanyl citrate - Naropin with fentanyl (New formulation) 23(4) 84-7
    		•
  • local anaesthetic - Naropin (New drug) 19(2) 38-40
    		•
    rosiglitazone
  • pharmacology 27(3) 67-70; 27(3) 70-4
    		•
  • letter 27(6) 138-41
    		•
  • type 2 diabetes - Avandia (New drug) 24(1) 20-3
    		•
    rosuvastatin
  • Crestor - hypercholesterolaemia (New drug) 29(6) 167-71
    		•
    Rotarix
  • see rotavirus vaccine 29(4) 112-5
    		•
    RotaTeq
  • see rotavirus vaccine 29(4) 112-5
    		•
    rotavirus vaccine
  • Rotarix (New drug) 29(4) 112-5
    		•
  • RotaTeq (New drug) 29(4) 112-5
    		•
    Roxiam
  • see remoxipride 17(1) 6-8
    		•
    Roxin
  • see norfloxacin 25(6) 147-51
    		•
    rubella
  • childhood immunisation 17(4) 91-4
    		•
  • measles, mumps, rubella vaccine - Priorix (New formulation) 22(4) 95-8
    		•
    Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager